본문 바로가기
KERD
논문KCI 등재

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: This study was performed to analyze cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and its impact on the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Methods: Five thousand five hundred and forty-nine cases of thyroid fine-needle aspiration cytology (FNAC) diagnosed between 2012 and 2014 were included in this study. Diagnostic categories based on TBSRTC were compared with final surgical diagnoses, and the ROM in each category was calculated both when NIFTP was included in malignant lesions and when excluded from malignant lesions. Results: Of the 5,549 thyroid FNAC cases, 1,891 cases underwent surgical resection. In final diagnosis, 1,700 cases were revealed as papillary thyroid carcinoma (PTC), and 25 cases were reclassified as NIFTP. The cytologic diagnoses of NIFTP were non-diagnostic in one, benign in five, atypia of undetermined significance (AUS) in 14, follicular neoplasm in two, and suspicious for malignancy in three cases. Collectively, NIFTP/encapsulated follicular variant of PTC (EFVPTC) were more frequently classified as benign, AUS, or follicular neoplasm and less frequently categorized as malignant compared to conventional PTCs. Exclusion of NIFTP from malignant diagnoses resulted in a slight decrease in malignancy rates in non-diagnostic, benign, AUS, follicular neoplasm, and suspicious for malignancy categories without any statistical significance. Conclusions: The decrease in the ROM was not significant when NIFTP was excluded from malignant lesions. In thyroid FNACs, NIFTP/EFVPTCs were mostly classified into indeterminate categories. Therefore, it might be feasible to separate NIFTP/EFVPTC from conventional PTC on FNAC to guide clinicians to conservative management for patients with NIFTP/EFVPTC.

Abstract

Background: This study was performed to analyze cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and its impact on the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). Methods: Five thousand five hundred and forty-nine cases of thyroid fine-needle aspiration cytology (FNAC) diagnosed between 2012 and 2014 were included in this study. Diagnostic categories based on TBSRTC were compared with final surgical diagnoses, and the ROM in each category was calculated both when NIFTP was included in malignant lesions and when excluded from malignant lesions. Results: Of the 5,549 thyroid FNAC cases, 1,891 cases underwent surgical resection. In final diagnosis, 1,700 cases were revealed as papillary thyroid carcinoma (PTC), and 25 cases were reclassified as NIFTP. The cytologic diagnoses of NIFTP were non-diagnostic in one, benign in five, atypia of undetermined significance (AUS) in 14, follicular neoplasm in two, and suspicious for malignancy in three cases. Collectively, NIFTP/encapsulated follicular variant of PTC (EFVPTC) were more frequently classified as benign, AUS, or follicular neoplasm and less frequently categorized as malignant compared to conventional PTCs. Exclusion of NIFTP from malignant diagnoses resulted in a slight decrease in malignancy rates in non-diagnostic, benign, AUS, follicular neoplasm, and suspicious for malignancy categories without any statistical significance. Conclusions: The decrease in the ROM was not significant when NIFTP was excluded from malignant lesions. In thyroid FNACs, NIFTP/EFVPTCs were mostly classified into indeterminate categories. Therefore, it might be feasible to separate NIFTP/EFVPTC from conventional PTC on FNAC to guide clinicians to conservative management for patients with NIFTP/EFVPTC.

참고문헌 (22)

  1. Baloch ZW, "Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology", Cancer Cytopathol, 124, pp.616~620 (2016)[DOI]
  2. Cibas ES, "The Bethesda System for Reporting Thyroid Cytopathology", Thyroid, 19, pp.1159~1165 (2009)[DOI]
  3. Cibas ES, "The 2017 Bethesda System for Reporting Thyroid Cytopathology", Thyroid, 27, pp.1341~1346 (2017)[DOI]
  4. Nikiforov YE, "Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors", JAMA Oncol, 2, pp.1023~1029 (2016)[DOI]
  5. Hauch A, "Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons", Ann Surg Oncol, 21, pp.3844~3852 (2014)[DOI]
  6. Iyer NG, "Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy", Cancer, 117, pp.4439~4446 (2011)[DOI]
  7. Ohori NP, "The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria", Cancer Cytopathol, 125, pp.692~700 (2017)[DOI]
  8. Strickland KC, "The impact of noninvasive follicular variant of papillary thyroid carcinoma on rates of malignancy for fine-needle aspiration diagnostic categories", Thyroid, 25, pp.987~992 (2015)[DOI]
  9. Zhou H, "Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)", Cancer Cytopathol, 126, pp.20~26 (2018)[DOI]
  10. Kiernan CM, "New terminology-noninvasive follicular neoplasm with papillary- like nuclear features (NIFTP) and its effect on the rate of malignancy at a single institution", Surgery, 163, pp.55~59 (2018)[DOI]
  11. Faquin WC, "Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology", Cancer Cytopathol, 124, pp.181~187 (2016)[DOI]
  12. Li W, "Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS", FLUS and FN, Diagn Cytopathol, pp.2018, 46[DOI]
  13. Mainthia R, "Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features", Surgery, 163, pp.60~65 (2018)[DOI]
  14. Singh R, "Patients with non-invasive follicular thyroid neoplasm with papillary-like nuclear features are unlikely to have malignant preoperative cytology", Ann Surg Oncol, 24, pp.3300~3305 (2017)[DOI]
  15. Hirokawa M, "Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan", Endocr J, 64, pp.1149~1155 (2017)[DOI]
  16. Bychkov A, "Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice", Thyroid, 27, pp.983~984 (2017)[DOI]
  17. Hung YP, "A user's guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)", Histopathology, 72, pp.53~69 (2018)[DOI]
  18. Jung CK, "The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations", J Clin Endocrinol Metab, 99, pp.E276~E285 (2014)[DOI]
  19. Brandler TC, "Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?", Cancer Cytopathol, 125, pp.378~388 (2017)[DOI]
  20. Strickland KC, "Preoperative cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a prospective analysis", Thyroid, 26, pp.1466~1471 (2016)[DOI]
  21. Chandler JB, "Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: implications for patient management", Cancer Cytopathol, 125, pp.865~875 (2017)[DOI]
  22. Maletta F, "Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology", Hum Pathol, 54, pp.134~142 (2016)[DOI]

관련 논문AI추천

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy나희영, 박소연대한병리학회 · Journal of Pathology and Translational Medicine2022 · 제56권 제6호Cytological Features That Differentiate Follicular Neoplasm from Mimicking Lesions고재수, 공준석, 김정순, 명재경, 박선후, 설혜실, 송우탁, 신명순, 이승숙, 하화정, 한강희대한병리학회 · Journal of Pathology and Translational Medicine2018 · 제52권 제2호Fine Needle Aspiration Cytology of Thyroid Follicular Neoplasm: Cytohistologic Correlation and Accuracy강창석, 민기옥, 서영진, 유창영, 임소영, 정지한, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2013 · 제47권 제1호Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia나희영, 박소연, 신수진, 정찬권, Andrey Bychkov, Jen-Fan Hang, Kaori Kameyama, Kennichi Kakudo, Miyoko Higuchi, Shinya Satoh, Shipra Agarwal, Yun Zhu, Zhiyan Liu대한병리학회 · Journal of Pathology and Translational Medicine2024 · 제58권 제6호Thyroid Cytology in India: Contemporary Review and Meta-analysisDeepali Jain, Shipra Agarwal대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제6호Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience김혜민, 남지해, 박지혜, 손은주, 윤선옥, 홍순원대한병리학회 · Journal of Pathology and Translational Medicine2014 · 제48권 제2호

이 간행물의 다른 논문 (11건)